2 unchanged sentences
There are no such matters pending that we currently believe are reasonably likely to have a material impact on our business or to our consolidated financial statements.
−Removed: On September 25, 2019, in a complaint filed in the Düsseldorf, Germany, District Court, Carl Zeiss Microscopy GmbH, a subsidiary of Carl Zeiss AG (Zeiss), sued Luxendo GmbH (Luxendo), a subsidiary of Bruker Corporation, for infringement of a recently registered German utility model patent licensed to Zeiss pertaining to one specific Luxendo product category.
−Removed: We intend to vigorously defend against this claim.
−Removed: On September 23, 2019, in a complaint filed in the Düsseldorf, Germany, District Court, Micromass UK Limited, a subsidiary of Waters Corporation, sued Bruker Corporation, as well as its affiliate, Bruker Daltonik GmbH, for infringement of a European patent pertaining to our timsTOF product line.
−Removed: On March 6, 2020, Bruker
−Removed: was notified that Micromass has expanded its complaint in Düsseldorf and now asserts another recently granted European patent in Germany.
−Removed: We intend to vigorously defend against these claims.
+Added: Details on recent legal matters can be found in Note 17 to our consolidated financial statements included in this Annual Report on Form 10-K under Item 8.
In addition, we are subject to regulation by national, state and local government agencies in the United States and other countries in which we operate.
1 unchanged sentence
These governmental investigations may result in the commencement of civil and criminal proceedings, fines, penalties and administrative remedies which could have a material adverse effect on our financial position, results of operations and/or liquidity.
−Removed: In August 2018, the Korea Fair Trade Commission (KFTC) informed us that it was conducting an investigation into the public tender bidding activities of a number of life science instrument companies operating in Korea, including Bruker Korea Co., Ltd (Bruker Korea).
−Removed: We cooperated fully with the KFTC and on June 16, 2019, the KFTC announced its decision to impose a fine of approximately $20,000 on Bruker Korea and declined to impose any criminal liability against Bruker Korea in connection with this matter.
−Removed: As a result of the KFTC’s decision, the Korea Public Procurement Service (PPS) imposed a three month suspension on Bruker Korea’s ability to bid for or conduct sales to Korean government entities, which will end on March 27, 2020.
−Removed: Sales to Korea government entities were less than 3% of our revenue for the year ended December 31, 2019.
−Removed: In late August 2019, the KFTC informed us that it was conducting a separate investigation into the public tender bidding activities of a number of life science instrument companies operating in Korea, including five public tenders involving Bruker Korea during 2015.
−Removed: We are cooperating fully with the KFTC and a hearing on the matter has been scheduled for April 17, 2020.
ITEM 4 MINE SAFETY DISCLOSURES
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.